IBDEI2TH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47292,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47292,1,4,0)
 ;;=4^C81.48
 ;;^UTILITY(U,$J,358.3,47292,2)
 ;;=^5001439
 ;;^UTILITY(U,$J,358.3,47293,0)
 ;;=C81.49^^209^2346^274
 ;;^UTILITY(U,$J,358.3,47293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47293,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47293,1,4,0)
 ;;=4^C81.49
 ;;^UTILITY(U,$J,358.3,47293,2)
 ;;=^5001440
 ;;^UTILITY(U,$J,358.3,47294,0)
 ;;=C81.70^^209^2346^233
 ;;^UTILITY(U,$J,358.3,47294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47294,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,47294,1,4,0)
 ;;=4^C81.70
 ;;^UTILITY(U,$J,358.3,47294,2)
 ;;=^5001441
 ;;^UTILITY(U,$J,358.3,47295,0)
 ;;=C81.71^^209^2346^219
 ;;^UTILITY(U,$J,358.3,47295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47295,1,3,0)
 ;;=3^Hodgkin Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47295,1,4,0)
 ;;=4^C81.71
 ;;^UTILITY(U,$J,358.3,47295,2)
 ;;=^5001442
 ;;^UTILITY(U,$J,358.3,47296,0)
 ;;=C81.72^^209^2346^227
 ;;^UTILITY(U,$J,358.3,47296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47296,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47296,1,4,0)
 ;;=4^C81.72
 ;;^UTILITY(U,$J,358.3,47296,2)
 ;;=^5001443
 ;;^UTILITY(U,$J,358.3,47297,0)
 ;;=C81.73^^209^2346^223
 ;;^UTILITY(U,$J,358.3,47297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47297,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47297,1,4,0)
 ;;=4^C81.73
 ;;^UTILITY(U,$J,358.3,47297,2)
 ;;=^5001444
 ;;^UTILITY(U,$J,358.3,47298,0)
 ;;=C81.74^^209^2346^215
 ;;^UTILITY(U,$J,358.3,47298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47298,1,3,0)
 ;;=3^Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47298,1,4,0)
 ;;=4^C81.74
 ;;^UTILITY(U,$J,358.3,47298,2)
 ;;=^5001445
 ;;^UTILITY(U,$J,358.3,47299,0)
 ;;=C81.75^^209^2346^221
 ;;^UTILITY(U,$J,358.3,47299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47299,1,3,0)
 ;;=3^Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47299,1,4,0)
 ;;=4^C81.75
 ;;^UTILITY(U,$J,358.3,47299,2)
 ;;=^5001446
 ;;^UTILITY(U,$J,358.3,47300,0)
 ;;=C81.76^^209^2346^225
 ;;^UTILITY(U,$J,358.3,47300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47300,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47300,1,4,0)
 ;;=4^C81.76
 ;;^UTILITY(U,$J,358.3,47300,2)
 ;;=^5001447
 ;;^UTILITY(U,$J,358.3,47301,0)
 ;;=C81.77^^209^2346^231
 ;;^UTILITY(U,$J,358.3,47301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47301,1,3,0)
 ;;=3^Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47301,1,4,0)
 ;;=4^C81.77
 ;;^UTILITY(U,$J,358.3,47301,2)
 ;;=^5001448
 ;;^UTILITY(U,$J,358.3,47302,0)
 ;;=C81.78^^209^2346^229
 ;;^UTILITY(U,$J,358.3,47302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47302,1,3,0)
 ;;=3^Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47302,1,4,0)
 ;;=4^C81.78
 ;;^UTILITY(U,$J,358.3,47302,2)
 ;;=^5001449
 ;;^UTILITY(U,$J,358.3,47303,0)
 ;;=C81.79^^209^2346^217
 ;;^UTILITY(U,$J,358.3,47303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47303,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47303,1,4,0)
 ;;=4^C81.79
 ;;^UTILITY(U,$J,358.3,47303,2)
 ;;=^5001450
 ;;^UTILITY(U,$J,358.3,47304,0)
 ;;=C81.90^^209^2346^234
 ;;^UTILITY(U,$J,358.3,47304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47304,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,47304,1,4,0)
 ;;=4^C81.90
